This is a discussion on FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates within the FDA News forum, part of the Industry News and Updates category; FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA issues an updated Early Communication about an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler). | industry_news | FDA News | 0 | 10-07-2008 10:37 AM |
| Epoetin alfa - Early Communication about an Ongoing Safety Review | industry_news | FDA News | 0 | 09-26-2008 11:42 AM |
| FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia. | industry_news | FDA News | 0 | 08-22-2008 02:44 PM |
| FDA issues an Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Re | industry_news | FDA News | 0 | 06-07-2008 06:30 PM |
| FDA issues an Early Communication about an Ongoing Safety Review for Botox | industry_news | FDA News | 0 | 02-26-2008 02:30 PM |